Page last updated: 2024-08-25

2-bromopalmitate and Cardiomegaly

2-bromopalmitate has been researched along with Cardiomegaly in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahllöf, B; Edgley, AJ; Lanne, B; Ljung, B; Oakes, ND; Thalén, PG1
Faccini, JM; Greaves, P; Higgins, AJ1

Other Studies

2 other study(ies) available for 2-bromopalmitate and Cardiomegaly

ArticleYear
PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.
    European journal of pharmacology, 2006, May-24, Volume: 538, Issue:1-3

    Topics: Animals; Blood Proteins; Body Weight; Carbon Radioisotopes; Cardiomegaly; Deoxyglucose; Dietary Fats; Dietary Supplements; Epoxy Compounds; Fatty Acids; Fatty Acids, Nonesterified; Glucose; Heart Ventricles; Insulin; Male; Palmitates; PPAR gamma; Propionates; Proteins; Rats; Rats, Wistar; Time Factors; Triglycerides; Tritium

2006
Coronary hyperemia and cardiac hypertrophy following inhibition of fatty acid oxidation. Evidence of a regulatory role for cytosolic phosphorylation potential.
    Advances in myocardiology, 1985, Volume: 6

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cardiomegaly; Coronary Circulation; Creatine; Cytosol; Dogs; Fatty Acids; Glycine; Hemodynamics; Isoproterenol; Organ Size; Oxidation-Reduction; Oxygen Consumption; Palmitates; Phosphocreatine; Phosphorylation

1985